Bracco Diagnostics Inc. And Amerinet, Inc. Announce Group Purchasing Agreement To Include Lumasontm (Sulfur Hexafluoride Lipid-Type A Microspheres) For Injectable Suspension For Contrast Echocardiography

MONROE TOWNSHIP, N.J.--(BUSINESS WIRE)--Bracco Diagnostics Inc., the U.S. affiliate of Bracco Imaging, one of the world’s leading companies in the diagnostic imaging business, and Amerinet, a leading national healthcare solutions organization, announced today the expansion of its group purchasing agreement to include Lumason. Under the terms of the agreement, Amerinet’s membership base of more than 82,000 provider organizations across the U.S., will have access to Bracco’s Lumason for their contrast enhanced echocardiography needs.

Help employers find you! Check out all the jobs and post your resume.